Correction: Development and validation of a prediction model for cognitive impairment in elderly patients with type 2 diabetes

• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.Adding/removing text In the abstract, [ there was an error regarding the data presentation associated with Table2]. Although the numerical data in the abstract remain unchanged, the description has been revised to accurately reflect the corrected Table2. This has been corrected to read: [Results: After analyzing the data, four factors remained independently associated with T2DM related cognitive impairment: age (OR = 1.100, 95% CI: 1.038-1.164, P = 0.001), HADS-D score (OR = 1.242, 95% CI: 1.081-1.426, P = 0.002), WMD (OR = 2.444, 95% CI: 1.137-5.254, P = 0.022), and HbA1c (OR = 1.264, 95% CI: 1.007-1.585, P = 0.043).] The original version of this article has been updated.Adding/removing text [In the published article, Table 2 was previously corrected. However, the corresponding text that referenced the data in Table 2 Frontiers Media SA 2 with cognitive impairment (Table 2): age (OR = 1.100, 95% CI: 1.038-1.164, P = 0.001) depressive symptoms (HADS-D score) (OR = 1.242, 95% CI: 1.081-1.426, P = 0.002), cerebral white matter disease (OR = 2.444, 95% CI: 1.137-5.254, P = 0.022), and HbA1c (OR = 1.264, 95% CI: 1.007-1.585, P = 0.043). Body mass index (BMI) demonstrated a borderline protective effect (OR = 0.906, 95% CI: 0.812-1.011, P = 0.078), while monocytes (OR = 0.046, 95% CI: 0.002-1.030, P = 0.052) and PHR (OR = 1.218, 95% CI: 0.982-1.513, P = 0.073) showed trends toward association. Advanced age was identified as an independent risk factor for cognitive impairment (OR = 1.100, 95% CI: 1.038-1.164, P = 0.001), consistent with findings from a cross-sectional study in a Chinese population.The presence of cerebral white matter disease also emerged as an independent risk factor(OR = 2.444, 95% CI: 1.137-5.254, P = 0.022).In addition, higher HADS-D scores were independently and positively associated with cognitive impairment (OR = 1.242, 95% CI: 1.081-1.426, P = 0.002), Elevated HbA1c remained as significant peditor (OR = 1.264 ) reinforcing the critical role of glycemic control in preserving cognitive function, as demonstrated in longitudinal studies. The borderline protective effect of BMI ((OR = 0.906, P = 0.078) aligns with the "obesity paradox" observed in some elderly populations,altjough this association requires further investigation.]"The original version of this article has been updated.